Soft tissue sarcomas: new opportunity of treatment with PARP inhibitors?

Monica MangoniMariangela SottiliGiulia SalvatoreDomenico CampanacciGuido ScocciantiGiovanni BeltramiCamilla Delli PaoliLuca DominiciVirginia MaragnaEmanuela OlmettoIcro MeattiniIsacco DesideriPierluigi BonomoDaniela GretoLorenzo Livi

Published in: La Radiologia medica (2018)

The use of PARP inhibitors in advanced stage STSs, alone or combined in multimodal treatments, is of great interest and warrants further investigations.

Keyphrases

dna damage
soft tissue
dna repair
pain management
combination therapy
chronic pain